Immediate Impact
2 by Nobel laureates 3 from Science/Nature 75 standout
Citing Papers
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Works of Fred Yang being referenced
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
2015
HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fred Yang | 379 | 751 | 162 | 296 | 15 | 840 | |
| Susan Johnson | 362 | 718 | 171 | 294 | 25 | 952 | |
| Steen H. Ingwersen | 351 | 605 | 110 | 227 | 30 | 852 | |
| Charles Atisso | 454 | 789 | 238 | 251 | 17 | 834 | |
| Lene Jensen | 450 | 702 | 152 | 325 | 10 | 819 | |
| Amanda Mather | 267 | 492 | 77 | 262 | 22 | 786 | |
| Zin Zin Htike | 350 | 764 | 177 | 269 | 14 | 877 | |
| George Tsoukas | 292 | 555 | 141 | 170 | 14 | 654 | |
| Nelun Wijayasinghe | 310 | 493 | 152 | 225 | 12 | 710 | |
| Michaël J.B. van Baar | 226 | 623 | 107 | 298 | 11 | 728 | |
| Mario Widel | 422 | 749 | 135 | 272 | 7 | 901 |
All Works
Loading papers...